Angewandte Chemie International Edition · 2015 · 113 citations · 20 references
PharmacyChemical BiologyMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyAllosteric Drug DesignAllosteric RegulationCovalent Drug DesignCovalent Inhibitor DesignLigand BindingPotency OptimizationAllosteric Drug DiscoveryAllosteric Kinase InhibitorsCovalent Allosteric InhibitorsCovalent InhibitorsCovalent Kinase InhibitorsMedicinal Chemistry ApplicationsPleckstrin Homology DomainsStructure-based Allosteric Drug Design
Targeting and stabilizing distinct kinase conformations is an instrumental strategy for dissecting conformation-dependent signaling of protein kinases. Herein the structure-based design, synthesis, and evaluation of pleckstrin homology (PH) domain-dependent covalent-allosteric inhibitors (CAIs) of the kinase Akt is reported. These inhibitors bind covalently to a distinct cysteine of the kinase and thereby stabilize the inactive kinase conformation. These modulators exhibit high potency and selectivity, and represent an innovative approach for chemical biology and medicinal chemistry research.
20
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten, Andrew L. Faber, Candice L. Horn et al. · Nature · 2007 · 1.3K citations
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru et al. · Molecular Cancer Therapeutics · 2010 · 938 citations · Full text
Medicine, Oncology, Pharmacology +17